- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04496804
Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis (BIPAMS-Brain)
February 2, 2022 updated by: Robert W Motl, University of Alabama at Birmingham
BIPAMS-Brain:Examining the Neural Effects of a Behavioral Intervention for Physical Activity in Multiple Sclerosis
Multiple sclerosis [MS] is a prevalent neurological disease that is the leading cause of irreversible neurological disability among young women and the second leading cause of disability among young men in the United States.
This disease results in the progressive loss of walking mobility and substantial worsening of cognition, symptoms, and quality of life over time.
There is evidence that physical activity is beneficially associated with aerobic fitness and brain structure and function in persons with MS.
Nevertheless, this population is strikingly sedentary and physically inactive.
This highlights a vital opportunity to improve aerobic fitness and brain health by developing behavioral interventions that increase physical activity.
To that end, this project is a Phase-II randomized control trial for examining the efficacy of a behavioral intervention that is based on social-cognitive theory and delivered through the Internet for increasing physical activity and, secondarily, improving aerobic fitness and brain structure and function in persons with MS.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35209
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosis of multiple sclerosis
- relapse free in the last 30 days
- being non-active defined as not engaging in regular activity (30 minutes accumulated per day) on more than 2 days of the week during the previous 6 months
- ambulate without assistance
- low risk for contraindications for MRI
Exclusion Criteria:
- moderate or high risk for undertaking strenuous or maximal exercise
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Behavioral Intervention for Physical Activity in MS (BIPAMS)
The current behavioral intervention consists of two primary components; an Internet website and one-on-one video chats with a behavioral coach.
The Internet website involves content delivered through interactive video courses.
The interactive video courses are based on elements of social cognitive theory.
Each courses consists of an introduction, the primary content, and a take home message.
The interactive courses include embedded, supplementary options such as videos on content and worksheets related to the topic.
A pedometer is provided for tracking steps, and these steps will be entered into the website so progress can be monitored.
The chats support adherence to the intervention, discussion of website material, supportive accountability, and reporting of adverse events/injuries.
The chats are conducted face-to-face through Skype.
The chats occur 7 times during the first 2 months, 4 times during the second 2 months, and twice during the final 2 months of the intervention.
|
A behavioral intervention that involves an Internet website and one-on-one video coaching calls for increasing physical activity in people with MS.
|
Sham Comparator: Wellness for MS (WellMS)
Provides an Internet website and one-on-one video chats that discuss materials about self-managing multiple sclerosis (MS) consequences and health indicators through methods other than physical activity.
The materials are transformations of brochures provided by the National MS Society, including Gait or Walking Problems: The Basic Facts; MS and Your Emotions; Pain: The Basic Facts; Solving Cognitive Problems; Taming Stress in MS; Food for Thought: MS and Nutrition; and Vitamins, Minerals, and Herbs: An Introduction.
The delivery of the Internet materials and chat sessions will occur on the same time schedule and frequency as the intervention condition, and will have a comparable time commitment.
The control condition will not involve tracking steps and a pedometer with not be provided.
|
A behavioral intervention that involves an Internet website and one-on-one video coaching calls for increasing wellness in people with MS.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Minutes of moderate to vigorous physical activity - Baseline
Time Frame: Assessment will be conducted before the intervention
|
Activity monitors are Actigraph accelerometers that participants will wear on an elastic belt around their waist for 7 days.
These activity monitors measure how frequently and how much an individual moves.
|
Assessment will be conducted before the intervention
|
Minutes of moderate to vigorous physical activity - Post intervention
Time Frame: Assessment will be conducted immediately after the intervention
|
Activity monitors are Actigraph accelerometers that participants will wear on an elastic belt around their waist for 7 days.
These activity monitors measure how frequently and how much an individual moves.
|
Assessment will be conducted immediately after the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cardiorespiratory fitness; oxygen consumption during exercise - baseline
Time Frame: Assessment will be conducted before the intervention
|
A graded exercise test on a treadmill.
Participants will walk at a quick pace on the treadmill and the incline will increase every 2 minutes until the participant is no longer able to keep pace with the treadmill.
|
Assessment will be conducted before the intervention
|
cardiorespiratory fitness; oxygen consumption during exercise - post intervention
Time Frame: Assessment will be conducted immediately after the intervention
|
A graded exercise test on a treadmill.
Participants will walk at a quick pace on the treadmill and the incline will increase every 2 minutes until the participant is no longer able to keep pace with the treadmill.
|
Assessment will be conducted immediately after the intervention
|
distance walked - baseline
Time Frame: Assessment will be conducted before the intervention
|
The six-minute walk test will be used to measure walking endurance.
The test involves walking for 6 minutes without stopping.
|
Assessment will be conducted before the intervention
|
distance walked - post-intervention
Time Frame: Assessment will be conducted immediately after the intervention
|
The six-minute walk test will be used to measure walking endurance.
The test involves walking for 6 minutes without stopping.
|
Assessment will be conducted immediately after the intervention
|
information processing speed; cognitive function - baseline
Time Frame: Assessment will be conducted before the intervention
|
The symbol digit modalities test will be used to measure information processing speed.
The test involves matching numbers to symbols.
|
Assessment will be conducted before the intervention
|
information processing speed; cognitive function - post intervention
Time Frame: Assessment will be conducted immediately after the intervention
|
The symbol digit modalities test will be used to measure information processing speed.
The test involves matching numbers to symbols.
|
Assessment will be conducted immediately after the intervention
|
volume of subcortical grey matter brain structures - baseline
Time Frame: Assessment will be conducted before the intervention
|
An MRI will be conducted to measure brain structure.
|
Assessment will be conducted before the intervention
|
volume of subcortical grey matter brain structures - post intervention
Time Frame: Assessment will be conducted immediately after the intervention
|
An MRI will be conducted to measure brain structure.
|
Assessment will be conducted immediately after the intervention
|
resting state functional brain connectivity - baseline
Time Frame: Assessment will be conducted before the intervention
|
An MRI will be conducted to measure brain function.
|
Assessment will be conducted before the intervention
|
resting state functional brain connectivity - post intervention
Time Frame: Assessment will be conducted immediately after the intervention
|
An MRI will be conducted to measure brain function.
|
Assessment will be conducted immediately after the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Robert Motl, PhD, University of Alabama at Birmingham
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 2, 2020
Primary Completion (Actual)
November 3, 2021
Study Completion (Actual)
November 3, 2021
Study Registration Dates
First Submitted
July 29, 2020
First Submitted That Met QC Criteria
July 29, 2020
First Posted (Actual)
August 3, 2020
Study Record Updates
Last Update Posted (Actual)
February 4, 2022
Last Update Submitted That Met QC Criteria
February 2, 2022
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 300005111
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
Clinical Trials on Behavioral Intervention for Physical Activity in MS (BIPAMS)
-
University of Illinois at ChicagoEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingMultiple SclerosisUnited States
-
University of Alabama at BirminghamCompletedMultiple Sclerosis | Restless Legs SyndromeUnited States
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedMultiple SclerosisUnited States
-
University of Alabama at BirminghamCompletedMultiple Sclerosis (MS)United States
-
University of Alabama at BirminghamNational Multiple Sclerosis SocietyNot yet recruitingMultiple Sclerosis, Relapsing-Remitting | Sexual DysfunctionUnited States
-
The University of Texas Health Science Center,...Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingMultiple SclerosisUnited States
-
Children's Mercy Hospital Kansas CityCompletedPhysical Activity | Patient EngagementUnited States
-
University of OttawaThe Ottawa Hospital; Queen's University; Consortium of Multiple Sclerosis CentersCompleted
-
Butler HospitalRecruitingAging | Hiv | Physical InactivityUnited States
-
Tel-Aviv Sourasky Medical CenterUnknownObesity | Overweight | Learning DisabilityIsrael